Vaxigrip Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Inactivated trivalent flu vaccine (split virion)

Indications/Uses

Active immunisation of adults, pregnant women & childn from 6 mth for prevention of flu disease caused by 2 influenza A virus subtypes & influenza B virus type. Passive protection of infants from birth to <6 mth following vaccination during pregnancy.

Click to view Vaxigrip detailed prescribing information

Dosage/Direction for Use

IM/SC Adult, pregnant women & childn 6 mth-17 yr 1 dose of 0.5 mL. Childn <9 yr who have not been previously vaccinated 2nd dose of 0.5 mL given after at least 4 wk interval.

Click to view Vaxigrip detailed prescribing information

Overdosage

View Vaxigrip overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity to vaccine, eggs (ovalbumin, chicken proteins), neomycin, formaldehyde, octoxinol-9.

Click to view Vaxigrip detailed prescribing information

Special Precautions

Anaphylactic reaction after previous inj. Not to be inj intravascularly. Not a protection for all vaccines. Postpone vaccination in acute febrile illness. Thrombocytopenia or bleeding disorder; syncope. Insufficient Ab response in patients w/ endogenous or iatrogenic immunosuppression. Infants <6 mth.

Click to view Vaxigrip detailed prescribing information

Use In Pregnancy & Lactation

Click to view Vaxigrip detailed prescribing information

Adverse Reactions

Inj site pain, tenderness, erythema, swelling, induration & ecchymosis, fever. Adults, elderly, childn from 24 mth & adolescents 9-17 yr: Headache; myalgia; malaise, shivering. Childn 6-23 mth: Decreased appetite; abnormal crying, irritability; drowsiness; vomiting. Childn 6-35 mth: Diarrhoea.

Click to view Vaxigrip detailed prescribing information

Drug Interactions

Reduced immunological response w/ immunosuppressant treatment.

Click to view Vaxigrip detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Vaxigrip detailed prescribing information

Storage

View Vaxigrip storage conditions for details to ensure optimal shelf-life.

Description

View Vaxigrip description for details of the chemical structure and excipients (inactive components).

Action

View Vaxigrip mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BB02 - influenza, inactivated, split virus or surface antigen ; Belongs to the class of influenza viral vaccines.

Regulatory Classification

Presentation/Packing

Form

Vaxigrip susp for inj (pre-filled syringe) 45 mcg/0.5 mL

Packing/Price

1's

Vaxigrip

influenza vaccine

Manufacturer:

Sanofi

Distributor:

Zuellig Pharma